Stock listing
Biogen Inc.
Selected listing: BIIB.USD · SIX · USD · CH
Biogen Inc. (SIX Swiss: BIIB.USD), Health Technology. Latest release Oct 2, 2026: Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week…
- Ticker
- SIX Swiss: BIIB.USD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX Swiss
- Currency
- USD
About Biogen Inc.
The company focuses on developing therapies for neurological diseases and has a strong portfolio of innovative treatments. Biogen is committed to advancing scientific research and improving patient outcomes in the field of neuroscience.
Latest news from Biogen Inc.
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 2, 2026
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 1, 2026
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 1, 2026
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
September 17, 2026
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
September 16, 2026
Events
Research Biogen Inc.
Alternate listings
BIIB:NASDAQ
US · USD
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
IDP:GETTEX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
BIIB:BCBA
AR · ARS
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
IDP:TRADEGATE
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
789617:LSX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
BIIB:BMV
MX · MXN
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
BIIBD:BCBA
AR · USD
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
789617:LS
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
BIIB:BCS
CL · USD
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
0R1B:LSE
GB · USD
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
IDP:FWB
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.
1BIIB:MIL
IT · EUR
Alternate listing for Biogen Inc.; the primary context on this page is BIIB.USD:SIX.